Carlo Buonerba

5.2k total citations
123 papers, 2.7k citations indexed

About

Carlo Buonerba is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Carlo Buonerba has authored 123 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Pulmonary and Respiratory Medicine, 41 papers in Oncology and 31 papers in Surgery. Recurrent topics in Carlo Buonerba's work include Prostate Cancer Treatment and Research (37 papers), Prostate Cancer Diagnosis and Treatment (18 papers) and Renal cell carcinoma treatment (14 papers). Carlo Buonerba is often cited by papers focused on Prostate Cancer Treatment and Research (37 papers), Prostate Cancer Diagnosis and Treatment (18 papers) and Renal cell carcinoma treatment (14 papers). Carlo Buonerba collaborates with scholars based in Italy, United States and Canada. Carlo Buonerba's co-authors include Giuseppe Di Lorenzo, Matteo Ferro, Sabino De Placido, Daniela Terracciano, Guru Sonpavde, Piera Federico, Sisto Perdonà, Riccardo Autorino, Giuseppe Lucarelli and Ottavio De Cobelli and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Carlo Buonerba

113 papers receiving 2.7k citations

Peers

Carlo Buonerba

PRM

SURGE

ONCOL

Gaetano Facchini Italy

Winston Tan United States

Hidefumi Kinoshita Japan

Laurent Guy France

Yusuke Demizu Japan

Ke‐Hung Tsui Taiwan

Piyush K. Agarwal United States

Kenichi Harada Japan

Kouji Izumi Japan

Linda Sugar Canada

Gaetano Facchini Italy

Carlo Buonerba

1.2k ×1.0

PRM

1.1k ×1.5

685 ×1.1

SURGE

1.2k ×1.9

ONCOL

684 ×1.2

Citations per year, relative to Carlo Buonerba Carlo Buonerba (= 1×) peers Gaetano Facchini

Countries citing papers authored by Carlo Buonerba

Since Specialization

Citations

This map shows the geographic impact of Carlo Buonerba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Buonerba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Buonerba more than expected).

Fields of papers citing papers by Carlo Buonerba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlo Buonerba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Buonerba. The network helps show where Carlo Buonerba may publish in the future.

Co-authorship network of co-authors of Carlo Buonerba

This figure shows the co-authorship network connecting the top 25 collaborators of Carlo Buonerba. A scholar is included among the top collaborators of Carlo Buonerba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlo Buonerba. Carlo Buonerba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spagnuolo, Carmela, et al.. (2024). Synergistic Combination of Quercetin and Mafosfamide in Treatment of Bladder Cancer Cells. Molecules. 29(21). 5176–5176. 1 indexed citations

Tufano, Antonio, Luigi Napolitano, Biagio Barone, et al.. (2024). Preoperative Albumin-to-Alkaline Phosphatase Ratio as an Independent Predictor of Lymph Node Involvement in Penile Cancer. Medicina. 60(3). 414–414. 7 indexed citations

Lorenzo, Giuseppe Di, Antonio Verde, Luca Scafuri, et al.. (2024). The Impact of Flavonoid Supplementation on Serum Oxidative Stress Levels Measured via D-ROMs Test in the General Population: The PREVES-FLAVON Retrospective Observational Study. Nutrients. 16(19). 3302–3302.

Ingenito, Concetta, et al.. (2023). PREVES: A Population-Based Survey Focused on Cancer and Nutrition. Oncology. 101(6). 369–374. 2 indexed citations

Troisi, Jacopo, Martina Lombardi, Giovanni Scala, et al.. (2022). A Metabolomics-Based Screening Proposal for Colorectal Cancer. Metabolites. 12(2). 110–110. 18 indexed citations

Crocetto, Felice, Biagio Barone, Matteo Ferro, et al.. (2022). Liquid biopsy in bladder cancer: State of the art and future perspectives. Critical Reviews in Oncology/Hematology. 170. 103577–103577. 66 indexed citations

Crocetto, Felice, Carlo Buonerba, Vincenzo Caputo, et al.. (2021). Urologic Malignancies: Advances in the Analysis and Interpretation of Clinical Findings. Future Science OA. 7(4). FSO674–FSO674. 35 indexed citations

Montella, Liliana, Lucia Altucci, Federica Sarno, et al.. (2021). Toward a Personalized Therapy in Soft-Tissue Sarcomas: State of the Art and Future Directions. Cancers. 13(10). 2359–2359. 6 indexed citations

Crocetto, Felice, Erika Di Zazzo, Carlo Buonerba, et al.. (2021). Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature. Nutrients. 13(11). 3750–3750. 40 indexed citations

10.

Ferro, Matteo, Evelina La Civita, Antonietta Liotti, et al.. (2021). Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer. Journal of Personalized Medicine. 11(3). 237–237. 71 indexed citations

11.

Tătaru, Octavian Sabin, Felice Crocetto, Biagio Barone, et al.. (2021). Fascin-1 and Its Role As a Serological Marker in Prostate Cancer: a Prospective case–control Study. Future Science OA. 7(9). FSO745–FSO745. 7 indexed citations

12.

Pisconti, Salvatore, Giuseppina Della Vittoria Scarpati, Carlo Buonerba, et al.. (2020). Management of Ewing Sarcoma Family of Tumors: A Short Description of a Rare Primitive Uterine pPNET and Literature Review. SHILAP Revista de lepidopterología. 1 indexed citations

13.

Buonerba, Carlo, Matteo Ferro, Pasquale Dolce, et al.. (2020). Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 151. 102992–102992. 36 indexed citations

14.

Pisconti, Salvatore, Giuseppina Della Vittoria Scarpati, Carlo Buonerba, et al.. (2020). <p>Management of Ewing Sarcoma Family of Tumors: A Short Description of a Rare Primitive Uterine pPNET and Literature Review</p>. OncoTargets and Therapy. Volume 13. 1179–1184. 3 indexed citations

15.

Pierri, Biancamaria, et al.. (2020). Population-Based Human Biomonitoring in the 'Land of Fires' Area: Innovations in Study Design and Procedures. Future Science OA. 7(1). FSO646–FSO646. 3 indexed citations

16.

Longo, Nicola, Marco Capece, Giuseppe Celentano, et al.. (2020). Clinical and Pathological Characteristics of Metastatic Renal Cell Carcinoma Patients Needing a Second-Line Therapy: A Systematic Review. Cancers. 12(12). 3634–3634. 13 indexed citations

17.

Terracciano, Daniela, Carlo Buonerba, Luca Scafuri, et al.. (2020). Perspective: Cancer Patient Management Challenges During the COVID-19 Pandemic. Frontiers in Oncology. 10. 2 indexed citations

18.

Ferro, Matteo, Daniela Terracciano, Carlo Buonerba, et al.. (2016). The Emerging Role of Obesity, Diet and Lipid Metabolism in Prostate Cancer. Future Oncology. 13(3). 285–293. 49 indexed citations

19.

Lorenzo, Giuseppe Di, Sergio Bracarda, Donatello Gasparro, et al.. (2016). Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer. Medicine. 95(2). e2299–e2299. 12 indexed citations

20.

Lorenzo, Giuseppe Di, Carlo Buonerba, Vittorino Montanaro, et al.. (2015). Third-Line Chemotherapy for Metastatic Urothelial Cancer. Medicine. 94(51). e2297–e2297. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact